Paul Glass, MD
Ophthalmology · Tucker, GANPI 1811952823
Payments from drug & device makers
Across 37 payments — averaging $105.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$498
- Iridex Corporation$420
- Eyepoint US, Inc.$378
- Genentech USA, Inc.$280
- Regeneron Healthcare Solutions, Inc.$231
- NEW World Medical,inc.$210
- plus $2K from 16 others
What the payments were for
- Food & beverage$3,919100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 5 | $498 |
| Iridex Corporation | 1 | $420 |
| Eyepoint US, Inc. | 3 | $378 |
| Genentech USA, Inc. | 2 | $280 |
| Regeneron Healthcare Solutions, Inc. | 2 | $231 |
| NEW World Medical,inc. | 1 | $210 |
| Amgen | 4 | $175 |
| Sight Sciences, Inc. | 2 | $162 |
| AbbVie | 3 | $152 |
| Glaukos Corporation | 1 | $146 |
| Carl Zeiss Meditec USA, Inc. | 1 | $128 |
| Alimera Sciences, Inc. | 1 | $127 |
| Mallinckrodt Hospital Products Inc. | 1 | $126 |
| Harrow Eye, LLC | 1 | $125 |
| Rxsight Inc | 1 | $125 |
| Dompe US, Inc. | 1 | $125 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $123 |
| Apellis Pharmaceuticals, Inc. | 1 | $119 |
| Bausch & Lomb Americas Inc. | 1 | $113 |
| Astellas Pharma US Inc | 1 | $105 |
| Novartis | 2 | $35 |
| Mallinckrodt Enterprises LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXYCU$250
- EYLEA$231
- Kahook Dual Blade$210
- Clearpath$210
- Ahmed Glaucoma Valve$210
- Streamline$210
- Via360$210
- SUSVIMO$150
- Clareon$147
- OMNI(R) SURGICAL SYSTEM (US)$147
- TEPEZZA$137
- VABYSMO$130
- CLARUS$128
- YUTIQ$128
- Iluvien$127
- ACTHAR$126
- Rhopressa$125
- Rocklatan$125
- VEVYE$125
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$125
How this compares
$3,919 in reported general payments places this provider in the 65th percentile of 481 ophthalmology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 191 | $2,985 |
| Prednisolone Acetate | 42 | $1,679 |
| Timolol Maleate | 90 | $739 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 33 | $621 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 48 | $594 |
| Ketorolac Tromethamine | 28 | $543 |
| Ofloxacin | 40 | $428 |
| Dorzolamide Hcl | 17 | $194 |
| Brimonidine Tartrate | 32 | $147 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Tucker
- Dennis MarcusAugusta$9.2M
- Robert StoltzMarietta$3.9M
- Eugene McLaurinSavannah$3.3M
- Clayton BlehmGainesville$1.7M
- Lakshmana KooragayalaMarietta$1.4M
- Douglas DayAtlanta$1.1M
- Jennifer KimMorrow$989K
- Thomas AabergAtlanta$959K
- Gagan SawhneyAtlanta$874K
- Lawrence WoodardAtlanta$578K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.